4551 — Torii Pharmaceutical Co Share News
0.000.00%
Last trade - 00:00- ¥178bn
- ¥144bn
- ¥60bn
Brief: Japan Tobacco Says Agrees To Discuss Terminating Licence Agreements For 6 Anti-Hiv Drugs With Gilead Sciences
Table: Torii Pharmaceutical - 6-MTH parent results
Table: Torii Pharmaceutical - Q1 parent results
Table: Torii Pharmaceutical -2017 parent results
Table: Torii Pharmaceutical -2017 parent forecast
Table: Torii Pharmaceutical - 9-MTH parent results
Brief: Torii Pharmaceutical says new drug application approval of allergen immunotherapy tablet for japanese cedar pollinosis
Table: Torii Pharmaceutical - 6-MTH parent results
Table: Torii Pharmaceutical - Q1 parent results
Table: Torii Pharmaceutical -2016 parent results
Table: Torii Pharmaceutical -2016 parent forecast
Table: Torii Pharmaceutical -9-MTH parent results
Brief: Menlo Therapeutics signs license agreement with Japan Tobacco, Torii Pharma for NK-1 receptor antagonist
Table: Torii Pharmaceutical -6-MTH parent results
Table: Torii Pharmaceutical -Q1 parent results
Table: Torii Pharmaceutical -2015 parent results
Table: Torii Pharmaceutical -2015 parent forecast
Brief: Alk Abello announces MITICURE available in Japan
Table: Torii Pharmaceutical -9-MTH parent results